Test environment running 7.6.6

Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Proton-pump inhibitor therapy and the development of dysplasia in patients with Barretts oesophagus

Thumbnail Image

Date

2004

Authors

Hillman, Lybus
Chiragakis, Louise
Shadbolt, Bruce
Kaye, R A
Clarke, Anthony

Journal Title

Journal ISSN

Volume Title

Publisher

Australasian Medical Association

Abstract

Objective: To examine whether proton-pump inhibitor (PPI) therapy influences the incidence and progression of dysplasia in patients with Barrett's oesophagus. Design and setting: Review of prospective data on patients undergoing surveillance with regular

Description

Keywords

Keywords: acetylsalicylic acid; biological marker; lansoprazole; nonsteroid antiinflammatory agent; omeprazole; pantoprazole; proton pump inhibitor; Barrett esophagus; cancer prevention; clinical practice; confidence interval; demography; disease course; disease se

Citation

URI

http://hdl.handle.net/1885/77269

Collections

Open Access Research

Source

Medical Journal of Australia

Type

Journal article

Book Title

Entity type

Access Statement

License Rights

DOI

Restricted until

2037-12-31

Downloads

File
Description
01_Hillman_Proton-pump_inhibitor_therapy_2004.pdf (132.14 KB)

DSpace software copyright © 2002-2026 LYRASIS